Therefore, the CD103+CD11b+ DCs in the mLNs of 4T1-inoculated mice stimulated by BG might induce IFN-γ-expressing CD4+ or CD8+ effector T cells, leading to equivalent IFN-γ expression compared to control mice even in the late stage of breast cancer development. The gene discussed is IFNG; the disease is breast cancer.